S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(0.18%) $0.928
USD/NOK
(0.26%) $10.87
USD/GBP
(-0.03%) $0.792
USD/RUB
(-0.24%) $92.35

Realtime updates for AegirBio AB (publ) [AEGIR.ST]

Exchange: STO Sector: Healthcare Industry: Medical Instruments & Supplies
Last Updated28 Mar 2024 @ 07:54

1.24% SEK 0.734

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 07:54):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

AegirBio AB (publ), a diagnostic company, develops and commercializes tests to follow the dosage of biological drugs. The company focuses on therapeutic drug monitoring of biologic therapies in the multiple sclerosis, cancer, and autoimmune diseases...

Stats
Today's Volume 21 512.00
Average Volume 166 746
Market Cap 22.65M
EPS SEK-0.950 ( 2023-09-30 )
Last Dividend SEK0 ( N/A )
Next Dividend SEK0 ( N/A )
P/E -0.0400
ATR14 SEK0.0120 (1.64%)

AegirBio AB (publ) Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

AegirBio AB (publ) Correlation - Currency/Commodity

The country flag 0.09
( neutral )
The country flag 0.03
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.06
( neutral )

AegirBio AB (publ) Financials

Annual 2022
Revenue: SEK1.71M
Gross Profit: SEK-23.71M (-1 389.57 %)
EPS: SEK-16.58
Q3 2023
Revenue: SEK36 000.00
Gross Profit: SEK36 000.00 (100.00 %)
EPS: SEK-0.950
Q2 2023
Revenue: SEK1 000.00
Gross Profit: SEK93 000.00 (9 300.00 %)
EPS: SEK-0.670
Q1 2023
Revenue: SEK56 000.00
Gross Profit: SEK-84 000.00 (-150.00 %)
EPS: SEK-0.650

Financial Reports:

No articles found.

AegirBio AB (publ)

AegirBio AB (publ), a diagnostic company, develops and commercializes tests to follow the dosage of biological drugs. The company focuses on therapeutic drug monitoring of biologic therapies in the multiple sclerosis, cancer, and autoimmune diseases. It offers moNATor, a first dose-monitoring laboratory test to test multiple sclerosis for healthcare professionals and patients; and Viraspec, a COVID-19 saliva test kit. The company was incorporated in 2019 and is based in Lund, Sweden.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators